Abingworth as of March 31, 2012
Portfolio Holdings for Abingworth
Abingworth holds 22 positions in its portfolio as reported in the March 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amarin Corporation | 44.9 | $89M | 7.9M | 11.31 | |
| Clovis Oncology | 16.5 | $33M | 1.3M | 25.19 | |
| Alnylam Pharmaceuticals (ALNY) | 10.1 | $20M | 1.8M | 11.06 | |
| Incyte Corporation (INCY) | 8.1 | $16M | 830k | 19.30 | |
| Astex Pharmaceuticals | 4.2 | $8.3M | 4.5M | 1.86 | |
| OncoGenex Pharmaceuticals | 4.0 | $8.0M | 604k | 13.29 | |
| Nektar Therapeutics | 2.6 | $5.3M | 664k | 7.92 | |
| Zogenix | 2.3 | $4.6M | 2.3M | 1.98 | |
| ISIS Pharmaceuticals | 1.2 | $2.3M | 268k | 8.78 | |
| Exelixis (EXEL) | 1.1 | $2.1M | 415k | 5.18 | |
| Novavax | 1.0 | $1.9M | 1.5M | 1.27 | |
| Celldex Therapeutics | 0.9 | $1.7M | 343k | 5.09 | |
| Alexza Pharmaceuticals | 0.9 | $1.7M | 2.9M | 0.60 | |
| Isis Pharmaceuticals Inc Del note 2.625% 2/1 | 0.6 | $1.2M | 1.3k | 970.31 | |
| Zalicus | 0.5 | $1.0M | 864k | 1.20 | |
| Cornerstone Therapeutics | 0.2 | $505k | 85k | 5.96 | |
| Allos Therapeutics | 0.2 | $392k | 265k | 1.48 | |
| Sunesis Pharmaceuticals | 0.2 | $370k | 129k | 2.86 | |
| AVANIR Pharmaceuticals | 0.2 | $385k | 113k | 3.42 | |
| Cardiome Pharma Corp | 0.2 | $337k | 481k | 0.70 | |
| EntreMed | 0.1 | $149k | 71k | 2.11 | |
| Poniard Pharmaceuticals (PARD) | 0.0 | $10k | 4.6k | 2.19 |
